Dr Amirpasha Moetazedian

Dr Amirpasha Moetazedian is a Lecturer in Medical Engineering at the University of Hull. His research sits at the interface of medical engineering, advanced manufacturing, biomaterials, microfluidics and translational biomedical technologies. He develops engineering-led platforms that enable more physiologically relevant disease models, functional biomaterials, 3D bioprinted tissues, wearable sensing systems and next-generation in vitro technologies for healthcare applications.

He is currently Deputy Lead for ARTEMIS, a UKRI-funded Research Cluster supported by the Medical Research Council, focused on advancing better treatment for cardiovascular diseases.

His work is organised around several interconnected research themes:

Advanced biomanufacturing and 3D bioprinting:

Dr Moetazedian’s research advances the design, control and application of additive manufacturing technologies for biomedical engineering. He has developed micro-scale design approaches for material extrusion additive manufacturing and modular 3D-printed microfluidic nozzle systems for bioprinting. These technologies support the fabrication of complex biological constructs, functional scaffolds, microfluidic devices and engineered tissue platforms.

Microfluidics, organ-on-chip systems and in vitro disease modelling:

A major focus of his research is the development of microfluidic and organ-on-chip technologies for modelling human tissues, vascular systems and disease processes under controlled biophysical and biochemical conditions. His group is particularly interested in creating more predictive in vitro models that can reduce reliance on conventional experimental systems and support mechanistic studies, drug testing and personalised medicine.

Biomaterials, tissue engineering and regenerative medicine:

Dr Moetazedian works on the design, processing and characterisation of biomaterials for tissue engineering and regenerative medicine. This includes the development of functional polymeric, composite and bioactive materials for 3D printing, bioprinting, scaffold fabrication and cell-supportive microenvironments. His research combines material design with advanced manufacturing to engineer structures that better replicate the physical, mechanical and biological properties of native tissues.

Artificial blood vessels, thrombosis and vascular engineering:

Dr Moetazedian is developing functional artificial blood vessel models that reproduce key structural, mechanical and biological features of native vasculature. These platforms are designed to support studies of thrombosis, vascular disease, endothelial function and blood–material interactions, with future potential as semi-high-throughput systems for therapeutic screening and disease modelling.

Collaborative and translational research:

Dr Moetazedian’s research is highly interdisciplinary and is built around collaboration with engineers, clinicians, biologists, material scientists and data scientists. Through these collaborations, his work connects advanced manufacturing and medical engineering with diabetes research, platelet biology, biomaterials, neuroscience, human disease modelling and translational healthcare innovation.

His collaborative network includes:

• Dr Gowsihan Poologasundarampillai, King’s College London
• Dr Amin Ardestani, HYMS
• Dr Simon Calaminus, HYMS
• Prof Tim Palmer, HYMS
• Dr Andy Gleadall, Loughborough University
• Prof Zameel Cader, University of Oxford
• Dr Abdullah Khan, University of Oxford
• Prof Akiko Obata, Nagoya Institute of Technology
• Dr Alessia Candeo, Polytechnic University of Milan